AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 283: R638-R646, 2002; doi:10.1152/ajpregu.00150.2002
0363-6119/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, H.-F.
Right arrow Articles by Harris, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, H.-F.
Right arrow Articles by Harris, R. C.
Vol. 283, Issue 3, R638-R646, September 2002

Prostaglandins that increase renin production in response to ACE inhibition are not derived from cyclooxygenase-1

Hui-Fang Cheng1, Sue-Wan Wang1, Ming-Zhi Zhang2, James A. McKanna2, Richard Breyer1, and Raymond C. Harris1

George M. O'Brien Kidney Disease Center, Division of Nephrology, Departments of 1 Medicine and 2 Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

It is well known that nonselective, nonsteroidal anti-inflammatory drugs inhibit renal renin production. Our previous studies indicated that angiotensin-converting enzyme inhibitor (ACEI)-mediated renin increases were absent in rats treated with a cyclooxygenase (COX)-2-selective inhibitor and in COX-2 -/- mice. The current study examined further whether COX-1 is also involved in mediating ACEI-induced renin production. Because renin increases are mediated by cAMP, we also examined whether increased renin is mediated by the prostaglandin E2 receptor EP2 subtype, which is coupled to Gs and increases cAMP. Therefore, we investigated if genetic deletion of COX-1 or EP2 prevents increased ACEI-induced renin expression. Age- and gender-matched wild-type (+/+) and homozygous null mice (-/-) were administered captopril for 7 days, and plasma and renal renin levels and renal renin mRNA expression were measured. There were no significant differences in the basal level of renal renin activity from plasma or renal tissue in COX-1 +/+ and -/- mice. Captopril administration increased renin equally [plasma renin activity (PRA): +/+ 9.3 ± 2.2 vs. 50.1 ± 10.9; -/- 13.7 ± 1.5 vs. 43.9 ± 6.6 ng ANG I · ml-1 · h-1; renal renin concentration: +/+ 11.8 ± 1.7 vs. 35.3 ± 3.9; -/- 13.0 ± 3.0 vs. 27.8 ± 2.7 ng ANG I · mg protein-1 · h-1; n = 6; P < 0.05 with or without captopril]. ACEI also increased renin mRNA expression (+/+ 2.4 ± 0.2; -/- 2.1 ± 0.2 fold control; n = 6-10; P < 0.05). Captopril led to similar increases in EP2 -/- compared with +/+. The COX-2 inhibitor SC-58236 blocked ACEI-induced elevation in renal renin concentration in EP2 null mice (+/+ 24.7 ± 1.7 vs. 9.8 ± 0.4; -/- 21.1 ± 3.2 vs. 9.3 ± 0.4 ng ANG I · mg protein-1 · h-1; n = 5) as well as in COX-1 -/- mice (SC-58236-treated PRA: +/+ 7.3 ± 0.6; -/- 8.0 ± 0.9 ng ANG I · ml-1 · h-1; renal renin: +/+ 9.1 ± 0.9; -/- 9.6 ± 0.5 ng ANG I · mg protein-1 · h-1; n = 6-7; P < 0.05 compared with no treatment). Immunohistochemical analysis of renin expression confirmed the above results. This study provides definitive evidence that metabolites of COX-2 rather than COX-1 mediate ACEI-induced renin increases. The persistent response in EP2 nulls suggests involvement of prostaglandin E2 receptor subtype 4 and/or prostacyclin receptor (IP).

angiotensin-converting enzyme inhibitor; cyclooxygenase-2 -/-; prostaglandin E2 receptor subtype 2


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. J. Welch, K. Patel, P. Modlinger, M. Mendonca, N. Kawada, K. Dennehy, S. Aslam, and C. S. Wilcox
Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2644 - H2649.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
H. Cheng, S. Wang, Y.-I. Jo, C.-M. Hao, M. Zhang, X. Fan, C. Kennedy, M. D. Breyer, G. W. Moeckel, and R. C. Harris
Overexpression of Cyclooxygenase-2 Predisposes to Podocyte Injury
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 551 - 559.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
R. C. Harris and M. D. Breyer
Update on Cyclooxygenase-2 Inhibitors
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 236 - 245.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
U. G. Friis, J. Stubbe, T. R. Uhrenholt, P. Svenningsen, R. M. Nusing, O. Skott, and B. L. Jensen
Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells
Am J Physiol Renal Physiol, November 1, 2005; 289(5): F989 - F997.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
K. Kohlstedt, R. Busse, and I. Fleming
Signaling via the Angiotensin-Converting Enzyme Enhances the Expression of Cyclooxygenase-2 in Endothelial Cells
Hypertension, January 1, 2005; 45(1): 126 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
F. Schweda, J. Klar, S. Narumiya, R. M. Nusing, and A. Kurtz
Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys
Am J Physiol Renal Physiol, September 1, 2004; 287(3): F427 - F433.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H.-F. Cheng and R. C. Harris
Cyclooxygenases, the Kidney, and Hypertension
Hypertension, March 1, 2004; 43(3): 525 - 530.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
P. B Persson
Renin: origin, secretion and synthesis
J. Physiol., November 1, 2003; 552(3): 667 - 671.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Scholz
Prostaglandins
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R512 - R514.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. B. Persson, A. Skalweit, R. Mrowka, and B.-J. Thiele
Control of renin synthesis
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R491 - R497.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. B. Persson
The kidney and hypertension
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2003; 284(5): R1176 - R1178.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. M. Stauss
Interaction of prostaglandins with the renin-angiotensin system
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1010 - R1011.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Mrowka, K. Steinhage, A. Patzak, and P. B. Persson
An evolutionary approach for identifying potential transcription factor binding sites: the renin gene as an example
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1147 - R1150.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online